ZTS: Buy with a $182.83 price target

Operating cash covers reported profit, but capital spending changes the cash picture.

Target for 2027-09-14: $182.83 USD, +150.6% versus the $72.97 weekly close on 2026-09-11. Price return only; dividends, fees and tax excluded.

Over 1 year (2025-09-12 to 2026-09-11), price changed -50.8% and trailing EPS changed +5.8%. A wider gap changes the earnings multiple; it does not establish fair value.

Over the latest four quarters, operating cash was 1.10 times net income. Review receivables, inventory and non-cash charges before judging the gap.

Over 1 year (2025-09-12 to 2026-09-11), price changed -50.8% and trailing EPS changed +5.8%. A wider gap changes the earnings multiple; it does not establish fair value.

Operating cash covers 1.10 times profit, but cash after capital spending covers 0.90 times. Cash generation is stronger before the investment bill is paid.

The latest quarterly operating margin was 38.0%, -2.0 percentage points from a year earlier. The full report separates sales growth from margin changes.

Watch whether cash after capital spending closes the gap with profit. It currently covers 0.90 times profit over four quarters.

The latest quarterly margin changed -2.0 percentage points from a year earlier. Check sales volumes, pricing and unusual gains in the next filing.

Recheck the valuation gap alongside profitability and growth after new results. A discount alone does not establish value.

Starting annual sales growth: 1.71%.

Net profit margin: 27.17%.

Review recorded on 2026-09-17. This is a dated summary of an automated company valuation. The full report includes the financial evidence, alternative scenarios and review history. Consult the latest report before using an earlier target. Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.